NIKI
Niki BioSolutions Inc.
NIKI | NASDAQ
$1.77
-$0.19 (-9.51%)
At close: Oct 30, 2026, 4:00 PM ET
$1.77
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 7:03 AM ET
TTM Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 | Q4 2020 Dec 31, 2020 | Q2 2020 Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 431.38K | 1.2M | 1.3M | 1.43M | 1.54M | 1.22M | 911.51K | 622.65K |
Cost of Revenue | n/a | n/a | n/a | 255.05K | 709.65K | 1.55M | 2.41M | 2.42M | 2.54M | 2.65M | 2.44M | 2.35M | 2.86M |
Gross Profit | n/a | n/a | n/a | -255K | -710K | -1.12M | -1.21M | -1.13M | -1.11M | -1.11M | -1.22M | -1.44M | -2.24M |
Operating Income | -402.77K | -402.77K | -402.77K | -2.87M | -6.86M | -10.53M | -15.6M | -17.51M | -18.17M | -19.21M | -21.1M | -19.9M | -18.28M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 149.73K | 149.73K | n/a | n/a | n/a | n/a |
Pretax Income | -1.38M | -1.84M | -1.22M | -3.43M | -395K | -4.34M | -15.4M | -11.53M | -12.74M | -27.11M | -5.19M | 4.92M | -17.47M |
Net Income | -1.36M | -1.98M | -1.36M | -3.56M | 18K | -2.83M | -13.4M | -9.8M | -10.85M | -25.05M | -2.81M | 7.07M | -15.8M |
Selling & General & Admin | 1.64M | 1.46M | 1.05M | 1.13M | 2.15M | 4.42M | 7.25M | 7.97M | 7.78M | 7.8M | 7.64M | 7.36M | 8.51M |
Research & Development | 352.88K | -23.3K | -265.09K | 1.5M | 4.39M | 5.2M | 6.74M | 8.16M | 8.89M | 9.91M | 11.8M | 10.6M | 7.18M |
Other Expenses | -170.75K | -1.01M | -942.37K | -726.33K | -540.87K | -204K | 407.93K | 260.93K | 386K | 392K | 437K | 496K | 348K |
Operating Expenses | 1.82M | 433.8K | -155.83K | 1.91M | 6M | 9.41M | 14.39M | 16.38M | 17.06M | 18.1M | 19.88M | 18.46M | 16.04M |
Interest Expense | 73.49K | 73.49K | 46.53K | 68.46K | 96.13K | 121.15K | 96.62K | 3.15K | -3.7B | -3.7B | -3.7B | -3.7B | 3.7B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.99M | -1.99M | -2.26M | -2.26M | -2.73M | -2.09M | 741.56K |
Cost & Expenses | 1.82M | 433.8K | -155.83K | 2.31M | 6.86M | 10.96M | 16.8M | 18.81M | 19.6M | 20.75M | 22.32M | 20.81M | 18.9M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.52K | 72.39K | 71.27K | 62.9K | 53.4K | 51.82K | 38.5K | 35.71K | 35.68K | 35.64K | 34.28K | 34.02K | 29.96K |
Shares Outstanding (Diluted) | 73.52K | 72.39K | 71.27K | 62.9K | 53.4K | 51.82K | 38.5K | 35.71K | 35.68K | 35.64K | 34.28K | 34.02K | 29.96K |
EPS (Basic) | -18.90 | -29.30 | -20.80 | -64.10 | 1.50 | -91.50 | -364.10 | -274.40 | -304.40 | -720.70 | -79.10 | 182.90 | -537.60 |
EPS (Diluted) | -18.90 | -29.30 | -20.80 | -64.10 | 1.50 | -91.50 | -364.10 | -274.40 | -304.40 | -720.70 | -79.10 | 182.90 | -537.60 |
EBITDA | -1.82M | -716.47K | -126.84K | -2.06M | 406K | -3.1M | -14.01M | -10.31M | -11.56M | -25.8M | -3.74M | 6.5M | -15.3M |
EBIT | -1.82M | -716.47K | -126.84K | -2.31M | -304K | -4.23M | -15.3M | -11.52M | -12.74M | -26.99M | -4.97M | 5.16M | -17.3M |
Depreciation & Amortization | n/a | n/a | n/a | 255.05K | 709.65K | 1.13M | 1.3M | 1.21M | 1.18M | 1.19M | 1.23M | 1.33M | 2M |
Add to Watchlist
Select watchlists to add or remove NIKI